retatrutide expected approval date FDA Status: July 2026 Update Retatrutide FDA Approval Status 2026:

p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice

In this article, we explain what current evidence says about GLP-1 medications and eye health, discuss symptoms patients should be aware of, and review when it may be appropriate to seek an eye examination

(Baar et al., Cell, 2017)

Some artificial sweeteners can cause bloating, gas, or digestive upset in sensitive individuals

Consistent with our findings, four cohort studies found no increased risk of suicidal ideation between GLP-1 RAs and SGLT-2 inhibitors [11, 12, 28, 29]

That matters since stress can fuel androgen levels